119 related articles for article (PubMed ID: 18460465)
1. A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis.
Komiya Y; Kurabe N; Katagiri K; Ogawa M; Sugiyama A; Kawasaki Y; Tashiro F
J Biol Chem; 2008 Jul; 283(27):18753-64. PubMed ID: 18460465
[TBL] [Abstract][Full Text] [Related]
2. FBI1/Akirin2 promotes tumorigenicity and metastasis of Lewis lung carcinoma cells.
Komiya Y; Akiyama H; Sakumoto R; Tashiro F
Biochem Biophys Res Commun; 2014 Feb; 444(3):382-6. PubMed ID: 24468084
[TBL] [Abstract][Full Text] [Related]
3. The FBI1/Akirin2 target gene, BCAM, acts as a suppressive oncogene.
Akiyama H; Iwahana Y; Suda M; Yoshimura A; Kogai H; Nagashima A; Ohtsuka H; Komiya Y; Tashiro F
PLoS One; 2013; 8(11):e78716. PubMed ID: 24223164
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
5. CBFA2T3-ZNF652 corepressor complex regulates transcription of the E-box gene HEB.
Kumar R; Cheney KM; McKirdy R; Neilsen PM; Schulz RB; Lee J; Cohen J; Booker GW; Callen DF
J Biol Chem; 2008 Jul; 283(27):19026-38. PubMed ID: 18456661
[TBL] [Abstract][Full Text] [Related]
6. Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter.
Ekerot M; Stavridis MP; Delavaine L; Mitchell MP; Staples C; Owens DM; Keenan ID; Dickinson RJ; Storey KG; Keyse SM
Biochem J; 2008 Jun; 412(2):287-98. PubMed ID: 18321244
[TBL] [Abstract][Full Text] [Related]
7. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
[TBL] [Abstract][Full Text] [Related]
8. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
McGilvray R; Walker M; Bartholomew C
FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
[TBL] [Abstract][Full Text] [Related]
9. Direct repression of the Mcl-1 promoter by E2F1.
Croxton R; Ma Y; Song L; Haura EB; Cress WD
Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
[TBL] [Abstract][Full Text] [Related]
10. Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway.
Miyake M; Goodison S; Lawton A; Gomes-Giacoia E; Rosser CJ
Oncogene; 2015 Feb; 34(7):890-901. PubMed ID: 24561529
[TBL] [Abstract][Full Text] [Related]
11. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
12. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner.
Attwooll C; Oddi S; Cartwright P; Prosperini E; Agger K; Steensgaard P; Wagener C; Sardet C; Moroni MC; Helin K
J Biol Chem; 2005 Jan; 280(2):1199-208. PubMed ID: 15536069
[TBL] [Abstract][Full Text] [Related]
13. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
14. Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter.
Ryser S; Massiha A; Piuz I; Schlegel W
Biochem J; 2004 Mar; 378(Pt 2):473-84. PubMed ID: 14609431
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activation of the mkp-1 gene by protein kinase A signaling and USF, but not c-Myc.
Sommer A; Burkhardt H; Keyse SM; Lüscher B
FEBS Lett; 2000 Jun; 474(2-3):146-50. PubMed ID: 10838075
[TBL] [Abstract][Full Text] [Related]
16. Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).
Santhekadur PK; Gredler R; Chen D; Siddiq A; Shen XN; Das SK; Emdad L; Fisher PB; Sarkar D
J Biol Chem; 2012 Jan; 287(5):3425-32. PubMed ID: 22167195
[TBL] [Abstract][Full Text] [Related]
17. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
Huang S; Jean D; Luca M; Tainsky MA; Bar-Eli M
EMBO J; 1998 Aug; 17(15):4358-69. PubMed ID: 9687504
[TBL] [Abstract][Full Text] [Related]
18. Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.
Tan K; Shaw AL; Madsen B; Jensen K; Taylor-Papadimitriou J; Freemont PS
J Biol Chem; 2003 Jun; 278(23):20507-13. PubMed ID: 12657635
[TBL] [Abstract][Full Text] [Related]
19. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
Barros JC; Marshall CJ
J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
[TBL] [Abstract][Full Text] [Related]
20. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
